...
search icon
rprx-img

Royalty Pharma Plc Share Price

RPRX
NSQ
$44.965
+$0.72
(1.63%)
1D
Industry: Pharmaceuticals Sector: Health Care

Royalty Pharma Plc Analyst Forecast

Royalty Pharma Plc Share Price Chart

Royalty Pharma Plc Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$18.91B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
25.2629
Volume info-icon
This is the total number of shares traded during the most recent trading day.
1.93M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
1.98%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.42
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$29.12 L
$45.24 H
$44.965

About Royalty Pharma Plc, Common Stock

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 14 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York. more

Industry: PharmaceuticalsSector: Health Care

Royalty Pharma Plc Stock Returns

Time FrameRPRXSectorS&P500
1-Week Return1.3%0.14%0.86%
1-Month Return9.91%-0.72%-0.47%
3-Month Return13.58%3.7%1.34%
6-Month Return22.27%19.92%8.86%
1-Year Return37.21%7%14.32%
3-Year Return16.45%16.96%67.75%
5-Year Return-6.47%34.22%77.15%
10-Year Return58.04%145.99%279.46%

Royalty Pharma Plc Financials

Dec '21Dec '22Dec '23Dec '24Dec '255YR TREND
Total Revenue2.29B2.24B2.35B2.26B2.38B[{"date":"2021-12-31","value":96.27,"profit":true},{"date":"2022-12-31","value":94.07,"profit":true},{"date":"2023-12-31","value":99.01,"profit":true},{"date":"2024-12-31","value":95.18,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Cost of Revenue452.84M904.24M560.66M732.46M-[{"date":"2021-12-31","value":50.08,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":62,"profit":true},{"date":"2024-12-31","value":81,"profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Gross Profit2.29B2.24B2.35B2.26B-[{"date":"2021-12-31","value":97.24,"profit":true},{"date":"2022-12-31","value":95.02,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":96.14,"profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Gross Margin100.00%100.00%100.00%100.00%-[{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Operating Expenses858.75M1.93B862.40M971.13M1.03B[{"date":"2021-12-31","value":44.49,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":44.68,"profit":true},{"date":"2024-12-31","value":50.31,"profit":true},{"date":"2025-12-31","value":53.13,"profit":true}]
Operating Income1.43B307.06M1.49B1.29B1.56B[{"date":"2021-12-31","value":91.74,"profit":true},{"date":"2022-12-31","value":19.69,"profit":true},{"date":"2023-12-31","value":95.68,"profit":true},{"date":"2024-12-31","value":82.87,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Total Non-Operating Income/Expense(302.12M)(186.63M)93.04M(139.80M)-[{"date":"2021-12-31","value":-324.71,"profit":false},{"date":"2022-12-31","value":-200.58,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-150.25,"profit":false},{"date":"2025-12-31","value":"-","profit":true}]
Pre-Tax Income1.24B230.06M1.70B1.33B1.32B[{"date":"2021-12-31","value":73.01,"profit":true},{"date":"2022-12-31","value":13.53,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":78.28,"profit":true},{"date":"2025-12-31","value":77.89,"profit":true}]
Income Taxes762.45M187.23M565.25M472.00M553.25M[{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":24.56,"profit":true},{"date":"2023-12-31","value":74.14,"profit":true},{"date":"2024-12-31","value":61.91,"profit":true},{"date":"2025-12-31","value":72.56,"profit":true}]
Income After Taxes478.75M42.83M1.13B858.81M-[{"date":"2021-12-31","value":42.19,"profit":true},{"date":"2022-12-31","value":3.77,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":75.68,"profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Income From Continuous Operations1.24B230.06M1.70B1.33B-[{"date":"2021-12-31","value":73.01,"profit":true},{"date":"2022-12-31","value":13.53,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":78.28,"profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Income From Discontinued Operations-----[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Net Income619.73M42.83M1.13B858.98M770.95M[{"date":"2021-12-31","value":54.61,"profit":true},{"date":"2022-12-31","value":3.77,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":75.69,"profit":true},{"date":"2025-12-31","value":67.93,"profit":true}]
EPS (Diluted)2.913.684.753.213.37[{"date":"2021-12-31","value":61.26,"profit":true},{"date":"2022-12-31","value":77.47,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":67.58,"profit":true},{"date":"2025-12-31","value":70.95,"profit":true}]

Royalty Pharma Plc Ratios

Royalty Pharma Plc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

RPRX
ROA (LTM) 5.22%
ROE (LTM) 13.10%

Royalty Pharma Plc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

RPRX
Debt Ratio Lower is generally better. Negative is bad. 0.50
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.50

Royalty Pharma Plc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

RPRX
Trailing PE 25.26
Forward PE 13.05
P/S (TTM) 10.97
P/B 2.93
Price/FCF 40
EV/R 11.04
EV/Ebitda 16.38
PEG 1.94

FAQs

What is Royalty Pharma Plc share price today?

Royalty Pharma Plc (RPRX) share price today is $44.965

Can Indians buy Royalty Pharma Plc shares?

Yes, Indians can buy shares of Royalty Pharma Plc (RPRX) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in RPRX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Royalty Pharma Plc be purchased?

Yes, you can purchase fractional shares of Royalty Pharma Plc (RPRX) via the Vested app. You can start investing in Royalty Pharma Plc (RPRX) with a minimum investment of $1.

How to invest in Royalty Pharma Plc shares from India?

You can invest in shares of Royalty Pharma Plc (RPRX) via Vested in three simple steps:

  • Click on Sign Up or Invest in RPRX stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Royalty Pharma Plc shares
What is Royalty Pharma Plc 52-week high and low stock price?

The 52-week high price of Royalty Pharma Plc (RPRX) is $45.24. The 52-week low price of Royalty Pharma Plc (RPRX) is $29.12.

What is Royalty Pharma Plc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Royalty Pharma Plc (RPRX) is 25.2629

What is Royalty Pharma Plc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Royalty Pharma Plc (RPRX) is 2.93

What is Royalty Pharma Plc dividend yield?

The dividend yield of Royalty Pharma Plc (RPRX) is 1.98%

What is the Market Cap of Royalty Pharma Plc?

The market capitalization of Royalty Pharma Plc (RPRX) is $18.91B

What is Royalty Pharma Plc's stock symbol?

The stock symbol (or ticker) of Royalty Pharma Plc is RPRX

How Can Investors Use Royalty Pharma Plc Share Price Data for Long-Term Investment Decisions?

Consider the share price of Royalty Pharma Plc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Royalty Pharma Plc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Royalty Pharma Plc shares for Indian investors?

When investing in Royalty Pharma Plc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Royalty Pharma Plc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Royalty Pharma Plc share price with other stocks in the same sector?

Rather than merely checking the share price of Royalty Pharma Plc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Royalty Pharma Plc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top